BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8867853)

  • 1. Mapping of the linear antigenic determinants from the Leishmania infantum histone H2A recognized by sera from dogs with leishmaniasis.
    Soto M; Requena JM; Quijada L; García M; Guzman F; Patarroyo ME; Alonso C
    Immunol Lett; 1995 Dec; 48(3):209-14. PubMed ID: 8867853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of the antigenic determinants of the Leishmania infantum gp63 protein recognized by antibodies elicited during canine visceral leishmaniasis.
    Morales G; Carrillo G; Requena JM; Guzman F; Gomez LC; Patarroyo ME; Alonso C
    Parasitology; 1997 Jun; 114 ( Pt 6)():507-16. PubMed ID: 9172421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis.
    Soto M; Requena JM; Quijada L; Perez MJ; Nieto CG; Guzman F; Patarroyo ME; Alonso C
    Clin Exp Immunol; 1999 Feb; 115(2):342-9. PubMed ID: 9933463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the antigenic determinants of the Leishmania infantum histone H3 recognized by antibodies elicited during canine visceral leishmaniasis.
    Soto M; Requena JM; Quijada L; Gomez LC; Guzman F; Patarroyo ME; Alonso C
    Clin Exp Immunol; 1996 Dec; 106(3):454-61. PubMed ID: 8973612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of dogs with six different candidate leishmaniasis vaccines composed of a chimerical recombinant protein containing ribosomal and histone protein epitopes in combination with different adjuvants.
    Poot J; Janssen LH; van Kasteren-Westerneng TJ; van der Heijden-Liefkens KH; Schijns VE; Heckeroth A
    Vaccine; 2009 Jul; 27(33):4439-46. PubMed ID: 19500553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of the linear antigenic determinants of the Leishmania infantum hsp70 recognized by leishmaniasis sera.
    Quijada L; Requena JM; Soto M; Gómez LC; Guzman F; Patarroyo ME; Alonso C
    Immunol Lett; 1996 Sep; 52(2-3):73-9. PubMed ID: 8905399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of two highly performing Leishmania infantum antigens for serodiagnosis of canine leishmaniosis.
    Rami M; Atarhouch T; Dakkak A
    Vet Parasitol; 2005 Nov; 134(1-2):25-31. PubMed ID: 16076527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of new Leishmania promastigote surface antigens, LaPSA-38S and LiPSA-50S, as major immunodominant excreted/secreted components of L. amazonensis and L. infantum.
    Bras-Gonçalves R; Petitdidier E; Pagniez J; Veyrier R; Cibrelus P; Cavaleyra M; Maquaire S; Moreaux J; Lemesre JL
    Infect Genet Evol; 2014 Jun; 24():1-14. PubMed ID: 24614507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.
    Lemesre JL; Holzmuller P; Cavaleyra M; Gonçalves RB; Hottin G; Papierok G
    Vaccine; 2005 Apr; 23(22):2825-40. PubMed ID: 15780731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. During active viscerocutaneous leishmaniasis the anti-P2 humoral response is specifically triggered by the parasite P proteins.
    Soto M; Requena JM; Quijada L; Angel SO; Gomez LC; Guzman F; Patarroyo ME; Alonso C
    Clin Exp Immunol; 1995 May; 100(2):246-52. PubMed ID: 7743663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.
    Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J
    Vaccine; 2007 Nov; 25(46):7962-71. PubMed ID: 17942199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological evaluation of experimentally infected dogs by LicTXNPx-ELISA and amastigote-flow cytometry.
    Silvestre R; Santarém N; Cunha J; Cardoso L; Nieto J; Carrillo E; Moreno J; Cordeiro-da-Silva A
    Vet Parasitol; 2008 Nov; 158(1-2):23-30. PubMed ID: 18848397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leishmania infantum: gene cloning of the GRP94 homologue, its expression as recombinant protein, and analysis of antigenicity.
    Larreta R; Soto M; Alonso C; Requena JM
    Exp Parasitol; 2000 Oct; 96(2):108-15. PubMed ID: 11052869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody response in dogs experimentally infected with Leishmania infantum: infection course antigen markers.
    Carrera L; Fermín ML; Tesouro M; García P; Rollán E; González JL; Méndez S; Cuquerella M; Alunda JM
    Exp Parasitol; 1996 Mar; 82(2):139-46. PubMed ID: 8617340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant guided polarization of the immune humoral response against a protective multicomponent antigenic protein (Q) from Leishmania infantum. A CpG + Q mix protects Balb/c mice from infection.
    Parody N; Soto M; Requena JM; Alonso C
    Parasite Immunol; 2004; 26(6-7):283-93. PubMed ID: 15541032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the preservative and temperature conditions on the stability of Leishmania infantum promastigotes antigens applied in a flow cytometry diagnostic method for canine visceral leishmaniasis.
    Gama Ker H; Dian de Oliveira Aguiar-Soares R; Mendes Roatt B; das Dores Moreira N; Coura-Vital W; Martins Carneiro C; Teixeira-Carvalho A; Martins-Filho OA; Cordeiro Giunchetti R; da Silveira-Lemos D; Barbosa Reis A
    Diagn Microbiol Infect Dis; 2013 Aug; 76(4):470-6. PubMed ID: 23726649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.
    Ramos I; Alonso A; Marcen JM; Peris A; Castillo JA; Colmenares M; Larraga V
    Vaccine; 2008 Jan; 26(3):333-44. PubMed ID: 18093705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. During canine viscero-cutaneous leishmaniasis the anti-Hsp70 antibodies are specifically elicited by the parasite protein.
    Quijada L; Requena JM; Soto M; Alonso C
    Parasitology; 1996 Mar; 112 ( Pt 3)():277-84. PubMed ID: 8728991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine visceral leishmaniasis: asymptomatic infected dogs as a source of L. infantum infection.
    Moshfe A; Mohebali M; Edrissian G; Zarei Z; Akhoundi B; Kazemi B; Jamshidi S; Mahmoodi M
    Acta Trop; 2009 Nov; 112(2):101-5. PubMed ID: 19595664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.